Edwin Horwitz, MD, PhD

Research Program

Cancer Immunology
Phone Number

404-785-1200
Email Address

edwin.horwitz@emory.edu

Biography

Edwin M. Horwitz, MD, PhD, is a professor in the Department of Pediatrics at Emory University School of Medicine. A board certified pediatric hematologist/oncologist, Dr. Horwitz serves as director of Transplantation Biology and Therapeutics at Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta.

Dr. Horwitz is a member of the Cancer Immunology Research Program at Winship Cancer Institute.

Education

Dr. Horwitz received his MD and PhD from Indiana University in Bloomington, Indiana, where he completed postdoctoral research in Biochemistry. He completed his residency in Pediatrics at Saint Louis Children's Hospital and his fellowship in Pediatric Hematology/Oncology at Washington University School of Medicine in Saint Louis, Missouri.

Titles & Roles

Professor, Department of Pediatrics

Emory University School of Medicine
Director of Transplantation Biology and Therapeutics

Aflac Cancer and Blood Disorders Center

Research

Dr. Horwitz's research efforts are currently focused in two areas, 1) studying interferon gamma primed mesenchymal stromal cells (MSC) as prophylaxis for graft versus host disease after bone marrow transplantation for leukemia, and 2) elucidating the specific mechanism(s) by which MSC prevent the alloreactivity underlying graft versus host disease without impairing the curative graft-versus-leukemia effect or the antiviral immunity after bone marrow transplantation.

Publications

Title/Journal	Authors	Publication Date
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells. Cytotherapy	KL Blanc, F Dazzi, K English, D Farge, J Galipeau, EM Horwitz, N Kadri, M Krampera, MM Lalu, J Nolta, NM Patel, Y Shi, DJ Weiss, S Viswanathan	04/01/2025
Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics. Cytotherapy	L Renesme, KD Cobey, MM Lalu, T Bubela, R Chinnadurai, J De Vos, R Dunbar, D Fergusson, D Freund, J Galipeau, E Horwitz, M Lê, M Matthay, D Moher, J Nolta, G Parker, DG Phinney, M Rao, JEJ Rasko, PRM Rocco, F Rossi, MR Myles, S Viswanathan, B Thébaud	02/01/2025
Single-cell multiomics to advance cell therapy. Cytotherapy	K Goss, EM Horwitz	02/01/2025
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine	BL Levine, MC Pasquini, JE Connolly, DL Porter, MP Gustafson, JJ Boelens, EM Horwitz, SA Grupp, MV Maus, FL Locke, F Ciceri, A Ruggeri, J Snowden, HE Heslop, CL Mackall, CH June, AM Sureda, MA Perales	02/01/2024
Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells. Frontiers in immunology	KK Parwani, GM Branella, RE Burnham, AJ Burnham, AYS Bustamante, EM Foppiani, KA Knight, BG Petrich, EM Horwitz, CB Doering, HT Spencer	01/01/2024
Mitochondrial metabolic flexibility is critical for CD8⁺ T cell antitumor immunity. Science advances	C Chen, H Zheng, EM Horwitz, S Ando, K Araki, P Zhao, Z Li, ML Ford, R Ahmed, CK Qu	12/08/2023
Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy. Cytotherapy	AJ Burnham, EM Foppiani, KL Goss, F Jang-Milligan, A Kamalakar, H Bradley, SL Goudy, CM Trochez, M Dominici, L Daley-Bauer, G Gibson, EM Horwitz	12/01/2023
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and cellular therapy	PA Patel, MF Teherani, Y Xiang, V Bernardo, S Chandrakasan, KP Goggin, A Haight, E Horwitz, WH Liang, SH Parikh, ML Schoettler, K Spencer, E Stenger, B Watkins, KM Williams, K Leung, P Jaggi, M Qayed	12/01/2023
Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature. Pediatric blood & cancer	C Hughes, A Harris, B Watkins, M Qayed, S Parikh, E Horwitz, E Stenger, KM Williams, ML Schoettler	10/01/2023
Obesity-induced dysregulation of skin-resident PPARγ⁺ Treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity	P Sivasami, C Elkins, PP Diaz-Saldana, K Goss, A Peng, M Hamersky, J Bae, M Xu, BP Pollack, EM Horwitz, CD Scharer, L Seldin, C Li	08/08/2023
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma. Journal for immunotherapy of cancer	S Raghunandan, M Pauly, WG Blum, M Qayed, MV Dhodapkar, M Elkhalifa, B Watkins, M Schoettler, E Horwitz, S Parikh, S Chandrakasan, K Leung, E Bryson, L Deeb, JL Kaufman, D Worthington-White, A Alazraki, JM Schecter, D Madduri, CC Jackson, E Zudaire, A Taraseviciute-Morris, A Babich, T Nesheiwat, M Vogel, N Lendvai, L Pacaud, KM Williams	05/01/2023
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. International journal of radiation oncology, biology, physics	SA Patel, TM Ma, JK Wong, BJ Stish, RT Dess, A Pilar, C Reddy, TB Wedde, WA Lilleby, R Fiano, GS Merrick, RG Stock, DJ Demanes, BJ Moran, PT Tran, DJ Krauss, EI Abu-Isa, TM Pisansky, CR Choo, DY Song, S Greco, C Deville, TL DeWeese, D Tilki, JP Ciezki, RJ Karnes, NG Nickols, MB Rettig, FY Feng, A Berlin, JD Tward, BJ Davis, RE Reiter, PC Boutros, T Romero, EM Horwitz, RD Tendulkar, ML Steinberg, DE Spratt, M Xiang, AU Kishan	03/01/2023
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. Blood advances	S Janardan, E Horwitz, B Watkins, K Williams, S Chandrakasan, M Qayed, S Parikh, S Arnold, F Keller, A Alazraki, M Schoettler, K Leung	05/24/2022
Culture Condition of Bone Marrow Stromal Cells Affects Quantity and Quality of the Extracellular Vesicles. International journal of molecular sciences	AL Scheiber, CA Clark, T Kaito, M Iwamoto, EM Horwitz, YI Kawasawa, S Otsuru	01/18/2022
Survival Associations between Patient Age and Treatment Modality in Olfactory Neuroblastoma: A Retrospective Population-Based Study. Journal of clinical medicine	AJ Burnham, PA Burnham, EM Horwitz	06/18/2021
Splenic macrophage phagocytosis of intravenously infused mesenchymal stromal cells attenuates tumor localization. Cytotherapy	S Hasgur, L Desbourdes, T Relation, KM Overholt, JR Stanek, AJ Guess, M Yu, P Patel, L Roback, M Dominici, S Otsuru, EM Horwitz	05/01/2021
Localized Sampling Enables Monitoring of Cell State via Inline Electrospray Ionization Mass Spectrometry. Biotechnology journal	MA Chilmonczyk, G Doron, PA Kottke, AL Culberson, K Leguineche, RE Guldberg, EM Horwitz, AG Fedorov	03/01/2021
Mesenchymal stromal cells in hematopoietic cell transplantation. Blood advances	AJ Burnham, LP Daley-Bauer, EM Horwitz	11/24/2020
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors. Cancer gene therapy	G Golinelli, G Grisendi, M Prapa, M Bestagno, C Spano, F Rossignoli, F Bambi, I Sardi, M Cellini, EM Horwitz, A Feletti, G Pavesi, M Dominici	08/01/2020
Key Metabolic Pathways in MSC-Mediated Immunomodulation: Implications for the Prophylaxis and Treatment of Graft Versus Host Disease. Frontiers in immunology	AJ Burnham, EM Foppiani, EM Horwitz	01/01/2020